Bioburden Testing Market by Product , Test, Application & End User - Forecast to 2019

The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.

The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the bioburden testing market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies and levels of output in order to remain successful.

Reasons to Buy the Report: 

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the bioburden testing market. The report analyzes the market by product, test type, application, end user, and region 

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioburden testing market

• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the bioburden testing market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bioburden testing products across regions

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioburden testing market

7 BIOBURDEN TESTING MARKET, BY PRODUCT 54

7.1 INTRODUCTION 55

7.2 CONSUMABLES 56

7.2.1 CULTURE MEDIA, REAGENTS, & KITS 59

7.2.2 OTHER CONSUMABLES 60

7.3 INSTRUMENTS 61

7.3.1 PCR 63

7.3.2 MICROSCOPES 64

7.3.3 AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS 66

7.3.4 OTHER INSTRUMENTS 67

8 BIOBURDEN TESTING MARKET, BY TEST TYPE 69

8.1 INTRODUCTION 70

8.2 AEROBIC COUNT 71

8.3 ANAEROBIC COUNT 72

8.4 FUNGI/MOLD COUNT 73

8.5 SPORE COUNT 74

 

9 BIOBURDEN TESTING MARKET, BY APPLICATION 76

9.1 INTRODUCTION 77

9.2 RAW MATERIALS TESTING 78

9.3 MEDICAL DEVICES TESTING 79

9.4 IN-PROCESS MATERIAL TESTING 80

9.5 STERILIZATION VALIDATION TESTING 81

9.6 EQUIPMENT CLEANING VALIDATION 83

10 BIOBURDEN TESTING MARKET, BY END USER 84

10.1 INTRODUCTION 85

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 86

10.3 MEDICAL DEVICE MANUFACTURERS 88

10.4 CONTRACT MANUFACTURING ORGANIZATIONS 89

10.5 MANUFACTURERS OF FOOD & BEVERAGE AND AGRICULTURAL PRODUCTS 91

10.6 MICROBIAL TESTING LABORATORIES 92

11 GEOGRAPHIC ANALYSIS 94

11.1 INTRODUCTION 95

11.2 NORTH AMERICA 97

11.2.1 U.S. 102

11.2.2 CANADA 105

11.3 EUROPE 108

11.4 ASIA 111

11.5 REST OF THE WORLD (ROW) 115

12 COMPETITIVE LANDSCAPE 119

12.1 OVERVIEW 119

12.2 COMPETITIVE SITUATION AND TRENDS 120

12.2.1 ACQUISITIONS 121

12.2.2 NEW PRODUCT AND SERVICE LAUNCHES 121

12.2.3 EXPANSIONS 122

12.2.4 OTHERS 122

13 COMPANY PROFILES 123

13.1 INTRODUCTION 123

13.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 124

13.2.1 BUSINESS OVERVIEW 124

13.2.2 PRODUCTS & SERVICES 125

13.2.3 RECENT DEVELOPMENTS 125

13.2.4 MNM VIEW 125

 

13.3 SIGMA-ALDRICH CORPORATION 126

13.3.1 BUSINESS OVERVIEW 126

13.3.2 PRODUCTS & SERVICES 127

13.3.3 RECENT DEVELOPMENTS 127

13.3.4 MNM VIEW 127

13.4 SGS S.A. 128

13.4.1 BUSINESS OVERVIEW 128

13.4.2 SERVICES 129

13.4.3 MNM VIEW 129

13.5 WUXI PHARMATECH (CAYMAN), INC. 130

13.5.1 BUSINESS OVERVIEW 130

13.5.2 SERVICES 131

13.5.3 MNM VIEW 131

13.6 MERCK & CO., INC. 132

13.6.1 BUSINESS OVERVIEW 132

13.6.2 PRODUCTS & SERVICES 133

13.6.3 RECENT DEVELOPMENTS 133

13.6.4 MNM VIEW 134

13.7 BECTON, DICKINSON, AND COMPANY 135

13.7.1 BUSINESS OVERVIEW 135

13.7.2 PRODUCT & SERVICES 136

13.7.3 KEY STRATEGY 136

13.8 NORTH AMERICAN SCIENCE ASSOCIATES, INC. (NAMSA) 137

13.8.1 BUSINESS OVERVIEW 137

13.8.2 SERVICES 137

13.8.3 KEY STRATEGY 137

13.8.4 RECENT DEVELOPMENTS 137

13.9 NELSON LABORATORIES, INC. 138

13.9.1 BUSINESS OVERVIEW 138

13.9.2 SERVICES 138

13.9.3 KEY STRATEGY 138

13.9.4 RECENT DEVELOPMENTS 138

13.10 PACIFIC BIOLABS 139

13.10.1 BUSINESS OVERVIEW 139

13.10.2 SERVICE PORTFOLIO 139

13.10.3 KEY STRATEGY 139

13.11 ATS LABS, INC. 140

13.11.1 BUSINESS OVERVIEW 140

13.11.2 SERVICES 140

13.11.3 KEY STRATEGY 140

13.11.4 RECENT DEVELOPMENTS 140

14 APPENDIX 141

14.1 INSIGHTS FROM INDUSTRY EXPERTS 141

14.2 DISCUSSION GUIDE 142

14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144

14.4 AVAILABLE CUSTOMIZATIONS 144

14.5 RELATED REPORTS 145